This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1975 Jun 15;31(6):669-71.

doi: 10.1007/BF01944619.

Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: implications for the treatment of Tardive dyskinesia

B K Koe

PMID: 237777
DOI: 10.1007/BF01944619

Monoamine oxidase inhibitors antagonize the acceleration of brain dopamine synthesis induced by neuroleptic drugs in vivo: implications for the treatment of Tardive dyskinesia

B K Koe. Experientia. 1975.

. 1975 Jun 15;31(6):669-71.

doi: 10.1007/BF01944619.

Author

B K Koe

PMID: 237777
DOI: 10.1007/BF01944619

No abstract available

PubMed Disclaimer

Similar articles

Early effects of monoamine oxidase inhibitors on dopamine metabolism and monoamine oxidase activity in the neostriatum of the rat.
Javoy F, Youdim MB, Agid Y, Glowinski J. Javoy F, et al. J Neural Transm. 1973;34(4):279-89. doi: 10.1007/BF01242750. J Neural Transm. 1973. PMID: 4149516 No abstract available.
Effect of psychoactive drugs on in vivo metabolism of 14C-histamine in mouse brain.
Schayer RW, Reilly MA. Schayer RW, et al. Arch Int Pharmacodyn Ther. 1973 May;203(1):123-9. Arch Int Pharmacodyn Ther. 1973. PMID: 4725329 No abstract available.
In vivo studies on the effect of monoamine oxidase inhibitors on dopamine and serotonin metabolism in rat brain areas.
Clement HW, Grote C, Wesemann W. Clement HW, et al. J Neural Transm Suppl. 1990;32:85-8. doi: 10.1007/978-3-7091-9113-2_10. J Neural Transm Suppl. 1990. PMID: 2128514 No abstract available.
Mechanism of action of vesicular monoamine transporter 2 (VMAT2) inhibitors in tardive dyskinesia: reducing dopamine leads to less "go" and more "stop" from the motor striatum for robust therapeutic effects.
Stahl SM. Stahl SM. CNS Spectr. 2018 Feb;23(1):1-6. doi: 10.1017/S1092852917000621. Epub 2017 Dec 18. CNS Spectr. 2018. PMID: 29249207 Review.
[New data on monoamine oxidase inhibitors].
Gorkin VZ. Gorkin VZ. Vestn Akad Med Nauk SSSR. 1971;26(11):23-8. Vestn Akad Med Nauk SSSR. 1971. PMID: 4942003 Review. Russian. No abstract available.

See all similar articles

Cited by

3-Methoxytyramine: its suitability as an indicator of synaptic dopamine release.
Waldmeier PC, Lauber J, Blum W, Richter WJ. Waldmeier PC, et al. Naunyn Schmiedebergs Arch Pharmacol. 1981 Jan;315(3):219-25. doi: 10.1007/BF00499838. Naunyn Schmiedebergs Arch Pharmacol. 1981. PMID: 6261159 No abstract available.
In vivo labelling and axonal transport of monoamine oxidase in the rat basal ganglia using radioactive pargyline.
Gramsbergen JB, Sebens JB, Korf J. Gramsbergen JB, et al. J Neural Transm. 1986;66(1):21-36. doi: 10.1007/BF01262955. J Neural Transm. 1986. PMID: 2426396

References

1. Eur J Pharmacol. 1970 May;10(2):193-205 - PubMed
1. Dis Nerv Syst. 1971 May;32(5):324-7 - PubMed
1. J Neural Transm. 1972;33(2):83-90 - PubMed
1. Dis Nerv Syst. 1969 Dec;30(12):843-7 - PubMed
1. Arch Gen Psychiatry. 1972 Oct;27(4):491-9 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database